United States · FDA National Drug Code directory
Bosentan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1018_33935d05-c8ff-4d9e-91bf-fac9072d25fd
- Product NDC
- 70771-1018
- Form
- TABLET
- Composition / generic term
- Bosentan
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190501
- Source listing expiry
- 20261231
Source-listed ingredients
- BOSENTAN — 125 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (70771-1018-1) · 70771-1018-1
- 10 BLISTER PACK in 1 CARTON (70771-1018-4) / 10 TABLET in 1 BLISTER PACK (70771-1018-2) · 70771-1018-4
- 500 TABLET in 1 BOTTLE (70771-1018-5) · 70771-1018-5
- 60 TABLET in 1 BOTTLE (70771-1018-6) · 70771-1018-6
- 180 TABLET in 1 BOTTLE (70771-1018-8) · 70771-1018-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →